scholarly article | Q13442814 |
P2093 | author name string | Matsushita T | |
Sadler JE | |||
P2860 | cites work | Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system | Q24628961 |
High-efficiency transformation of mammalian cells by plasmid DNA | Q27860469 | ||
Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex | Q28255295 | ||
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity | Q29618557 | ||
von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure | Q33899746 | ||
Primary structure of two-chain botrocetin, a von Willebrand factor modulator purified from the venom of Bothrops jararaca | Q36081875 | ||
von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib | Q37255563 | ||
Expression of von Willebrand factor "Normandy": an autosomal mutation that mimics hemophilia A. | Q37552867 | ||
Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin | Q38336125 | ||
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose | Q39218339 | ||
Induction of specific storage organelles by von Willebrand factor propolypeptide | Q41699095 | ||
High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis | Q41824916 | ||
Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca | Q43916499 | ||
Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli | Q44699205 | ||
Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gel. | Q44944528 | ||
Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin | Q45066549 | ||
Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling | Q45882688 | ||
Additivity of mutational effects in proteins | Q46528565 | ||
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 13406-13414 | |
P577 | publication date | 1995-06-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Identification of amino acid residues essential for von Willebrand factor binding to platelet glycoprotein Ib. Charged-to-alanine scanning mutagenesis of the A1 domain of human von Willebrand factor | |
P478 | volume | 270 |
Q39159765 | A biophysical view on von Willebrand factor activation. |
Q51823633 | A covalent oxidoreductase intermediate in propeptide-dependent von Willebrand factor multimerization. |
Q41150359 | A discrete site modulates activation of I domains. Application to integrin alphaMbeta2. |
Q37168411 | A mechanism for localized dynamics-driven affinity regulation of the binding of von Willebrand factor to platelet glycoprotein Ibα. |
Q44316600 | A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease |
Q24324184 | A pH-regulated dimeric bouquet in the structure of von Willebrand factor |
Q47403129 | A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation |
Q37393334 | Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza |
Q30618745 | An HMM-based algorithm for evaluating rates of receptor-ligand binding kinetics from thermal fluctuation data |
Q27627500 | An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain |
Q33408427 | An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura |
Q30443824 | Assembly of Weibel-Palade body-like tubules from N-terminal domains of von Willebrand factor |
Q36986074 | Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. |
Q42620255 | Cloning of the cDNA for murine von Willebrand factor and identification of orthologous genes reveals the extent of conservation among diverse species |
Q38359108 | Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha |
Q44600729 | Crystal Structure of NMC-4 Fab anti-von Willebrand Factor A1 Domain |
Q24563636 | Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin |
Q27639267 | Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation |
Q27748925 | Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab |
Q24319306 | Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations |
Q35193294 | Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease |
Q34062531 | Flow-induced beta-hairpin folding of the glycoprotein Ibalpha beta-switch |
Q34529610 | Functional property of von Willebrand factor under flowing blood |
Q34494411 | GPIbα-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease |
Q43146191 | Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis |
Q44752490 | Identification of the amino acid residues of the platelet glycoprotein Ib (GPIb) essential for the von Willebrand factor binding by clustered charged-to-alanine scanning mutagenesis |
Q24293697 | Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond |
Q45192183 | Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction |
Q45876636 | L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand disease |
Q58099010 | Long-ranged Protein-glycan Interactions Stabilize von Willebrand Factor A2 Domain from Mechanical Unfolding |
Q22253890 | Mapping the glycoprotein Ib-binding site in the von willebrand factor A1 domain |
Q31048172 | Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ibalpha using optical tweezers |
Q56426952 | Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease |
Q41731691 | Modeling and functional analysis of the interaction between von Willebrand factor A1 domain and glycoprotein Ibalpha |
Q40937677 | Molecular basis of von Willebrand disease |
Q35922561 | N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress. |
Q39147112 | New Concepts and Mechanisms of Platelet Activation Signaling |
Q33364143 | O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors |
Q35110960 | Phylogenetic and functional analysis of histidine residues essential for pH-dependent multimerization of von Willebrand factor. |
Q30577008 | Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress |
Q30483148 | Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. |
Q33740244 | Recombinant von Willebrand factor: potential therapeutic use. |
Q38317425 | Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-V. |
Q58824559 | Storage and secretion of naturally occurring von Willebrand factor A domain variants |
Q27639366 | Structural basis of von Willebrand factor activation by the snake toxin botrocetin |
Q27931947 | Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. |
Q33392975 | Targeting von Willebrand factor and platelet glycoprotein Ib receptor |
Q37289199 | The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα. |
Q46899655 | The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen |
Q34421530 | The molecular biology of von Willebrand disease |
Q24292709 | The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction |
Q36013413 | Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi |
Q73478153 | Two novel anti-von Willebrand factor monoclonal antibodies |
Q50214764 | Vwf K1362A resulted in failure of protein synthesis in mice |
Q41651628 | von Willebrand factor: biological function and molecular defects |
Search more.